Nurse Practitioner · Hot Springs, AR
NPI
1831662246
Since 2019
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1455 Higdon Ferry Rd Ste B
Hot Springs, AR, 71913
Phone (501) 623-2731
Groups this clinician bills Medicare through
Medicare paid, 2024
$631K
45,790 services
Medicare patients, 2024
472
Average age 73
Drug cost, 2024
$2.6M
5,484 prescriptions
Company payments, 2025
$587
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natalie K Brown was code J3111 (injection, romosozumab-aqqg, 1 mg), 27,090 times for 25 patients. In total Natalie K Brown billed 45,790 services in 28 codes, and Medicare paid $631K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 27,090 | 25 | $8.53 | $231K |
| J0897 Injection, denosumab, 1 mg | Office | 15,000 | 154 | $20.30 | $304K |
| 99214 Office E&M - Established | Office | 613 | 325 | $67.68 | $41K |
| 36415 Venipuncture Blood Collection | Office | 430 | 287 | $8.63 | $3,711 |
| 96372 Injection Administration | Office | 390 | 177 | $8.56 | $3,339 |
| 83036 Blood Count | Office | 364 | 171 | $9.37 | $3,411 |
| 80053 Clinical Chemistry | Office | 320 | 240 | $10.24 | $3,278 |
| 82306 Clinical Chemistry | Office | 285 | 205 | $28.92 | $8,241 |
| 99213 Office E&M - Established | Office | 272 | 206 | $50.24 | $14K |
| 84443 Clinical Chemistry | Office | 207 | 115 | $16.06 | $3,323 |
| 84439 Clinical Chemistry | Office | 178 | 89 | $8.60 | $1,530 |
| 95251 Test - Miscellaneous | Office | 168 | 78 | $19.85 | $3,335 |
| 84481 Clinical Chemistry | Office | 139 | 82 | $16.09 | $2,237 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 98 | 85 | $10.12 | $991 |
| 83970 Clinical Chemistry | Office | 83 | 65 | $40.45 | $3,357 |
By year: 2022 $374K for 25,852 services; 2023 $579K for 46,288 services; 2024 $631K for 45,790 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 430 | 287 | $8.63 | $3,711 |
| 83036 Blood Count | 364 | 171 | $9.37 | $3,411 |
| 80053 Clinical Chemistry | 320 | 240 | $10.24 | $3,278 |
| 82306 Clinical Chemistry | 285 | 205 | $28.92 | $8,241 |
| 84443 Clinical Chemistry | 207 | 115 | $16.06 | $3,323 |
| 84439 Clinical Chemistry | 178 | 89 | $8.60 | $1,530 |
| 84481 Clinical Chemistry | 139 | 82 | $16.09 | $2,237 |
| 83970 Clinical Chemistry | 83 | 65 | $40.45 | $3,357 |
| 82570 Clinical Chemistry | 39 | 38 | $4.98 | $194 |
| 82043 Clinical Chemistry | 39 | 38 | $5.55 | $216 |
Medicare prescription drug claims, 2024
In 2024, the drug Natalie K Brown prescribed most often to Medicare patients was Ozempic (Semaglutide), with 598 prescriptions and refills. In total Natalie K Brown wrote 5,484 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 598 | 724 | 98 | $685K |
| Levothyroxine Sodium Generic | 490 | 917 | 91 | $3,171 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 481 | 761 | 115 | $73K |
| Glimepiride Generic | 376 | 926 | 103 | $4,019 |
| Metformin Hcl Generic | 273 | 667 | 81 | $1,721 |
| Farxiga Dapagliflozin Propanediol | 225 | 358 | 42 | $195K |
| Metformin Hcl Er Metformin Hcl | 207 | 458 | 58 | $2,153 |
| Tresiba Flextouch U-100 Insulin Degludec | 178 | 253 | 44 | $137K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 157 | 210 | 36 | $81K |
| Novolog Flexpen Insulin Aspart | 150 | 188 | 40 | $35K |
| Prolia Denosumab | 138 | 817 | 88 | $242K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 138 | 162 | 32 | $42K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 124 | 252 | 41 | $12K |
| Jardiance Empagliflozin | 119 | 246 | 33 | $147K |
| Mounjaro Tirzepatide | 107 | 112 | 21 | $121K |
Brand drugs: 3,492 claims; generic drugs: 1,564 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natalie K Brown $587 ($587 in general payments such as food, travel and fees) from 19 companies. The largest payer was Tandem Diabetes Care, Inc. with $102.
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. TNDM | 4 | $102 |
| Radius Health, Inc. | 2 | $66.94 |
| Abbvie Inc. ABBV | 3 | $54.27 |
| Beta Bionics, Inc. BBNX | 2 | $53.34 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $42.17 |
| Amgen Inc. AMGN | 2 | $28.66 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $27.15 |
| Abbott Laboratories ABT | 1 | $24.46 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $21.15 |
| Recordati_rare_diseases_inc. | 1 | $21.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.